Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. STE
stocks logo

STE

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
1.48B
+8.07%
2.530
+9.05%
1.60B
+7.81%
2.875
+4.93%
1.49B
+6.86%
2.535
+8.33%
Estimates Revision
The market is revising Upward the revenue expectations for STERIS plc (STE) for FY2026, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by 6.41%.
Revenue Estimates for FY2026
Revise Upward
up Image
+0.11%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+1.06%
In Past 3 Month
Stock Price
Go Up
up Image
+6.41%
In Past 3 Month
Wall Street analysts forecast STE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STE is 289.33 USD with a low forecast of 285.00 USD and a high forecast of 295.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast STE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STE is 289.33 USD with a low forecast of 285.00 USD and a high forecast of 295.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 261.020
sliders
Low
285.00
Averages
289.33
High
295.00
Current: 261.020
sliders
Low
285.00
Averages
289.33
High
295.00
KeyBanc
Brett Fishbin
Overweight
maintain
$277 -> $288
2025-07-22
Reason
KeyBanc
Brett Fishbin
Price Target
$277 -> $288
2025-07-22
maintain
Overweight
Reason
KeyBanc analyst Brett Fishbin raised the firm's price target on Steris to $288 from $277 and keeps an Overweight rating on the shares. The firm notes that underlying MedTech trends appear positive heading into Q2 earnings season, and KeyBanc believes sub-sector underperformance this year has been more attributable to macro uncertainties such as the impact of tariffs. Specifically, the firm's Key First Look Data has indicated a high-single digit volume growth in the hospital category through Q2. KeyBanc continues to view tariffs as the biggest overhang to the group, but consensus estimates at least now incorporate the known base-case impacts.
Morgan Stanley
Equal Weight -> Overweight
upgrade
$260 -> $276
2025-07-15
Reason
Morgan Stanley
Price Target
$260 -> $276
2025-07-15
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Steris to Overweight from Equal Weight with a price target of $276, up from $260. The firm's work on the potential margin gains from the shift to E-Beam, consolidation of volumes and pricing power on NESHAP compliance costs, improving bioprocessing trends, and potential tailwind from Olympus' import ban into the U.S., all leave the firm more positive on Steris, the analyst tells investors in a research note.
Jefferies
David Windley
Hold
initiated
$263
2025-05-29
Reason
Jefferies
David Windley
Price Target
$263
2025-05-29
initiated
Hold
Reason
Citizens JMP
Outperform
maintain
$265 -> $280
2025-05-16
Reason
Citizens JMP
Price Target
$265 -> $280
2025-05-16
maintain
Outperform
Reason
Citizens JMP raised the firm's price target on Steris to $280 from $265 and keeps an Outperform rating on the shares. Steris ended fiscal 2025 with a strong quarter that included a marginal beat on the top line and 5% bottom-line upside, the analyst tells investors in a research note. The company has built an impressive track record of consistent execution and the portfolio remains largely non-elective in nature, and fiscal 2026 should be another solid year for the company and the stock, Citizens says.
JMP Securities
David Turkaly
Buy
Reiterates
$265
2025-04-10
Reason
JMP Securities
David Turkaly
Price Target
$265
2025-04-10
Reiterates
Buy
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-04-07
Reason
Needham
Mike Matson
Price Target
n/a
2025-04-07
Reiterates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for STERIS plc (STE.N) is 24.39, compared to its 5-year average forward P/E of 24.59. For a more detailed relative valuation and DCF analysis to assess STERIS plc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
24.59
Current PE
24.39
Overvalued PE
27.08
Undervalued PE
22.11

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
16.73
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
18.53
Undervalued EV/EBITDA
14.93

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.08
Current PS
0.00
Overvalued PS
4.51
Undervalued PS
3.65
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 17029.8% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 17029.8% over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

STE News & Events

Events Timeline

(ET)
2025-11-06
09:55:02
Significant Early Gainers in Liquid Options on November 6th
select
2025-11-05 (ET)
2025-11-05
18:06:19
Steris increases FY26 adjusted EPS forecast to $10.15-$10.30, up from $9.90-$10.15
select
2025-11-05
18:04:50
Steris announces Q2 adjusted earnings per share of $2.47, surpassing consensus estimate of $2.35.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.0
02:39 AMCNBC
A lesser-known medical device stock shows potential for a 20% increase, based on chart analysis.

  • Sector Performance: The health care sector, particularly medical devices, is showing signs of recovery, with the SPDR Health Care Select Sector ETF (XLV) and biotech stocks performing well, while Idexx Labs (IDXX) has reached all-time highs.

  • Stock Analysis: Steris (STE), a leader in sterilization and infection prevention, is highlighted as a strong investment opportunity, showing a favorable risk/reward setup with potential gains of 20%-25% as it breaks above key resistance levels.

  • Market Trends: The medical device sector is gaining traction, with Steris outperforming the sector average, indicating a rotation of investor interest towards this area.

  • Investment Advice: The content emphasizes the importance of setting risk parameters and suggests consulting a financial advisor before making investment decisions, as the information provided is general and not tailored to individual circumstances.

[object Object]
Preview
3.0
12-02CNBC
Medical Device Stocks Exhibit 'Cup-and-Handle' Chart Pattern: Implications for the Sector

  • Health Care Sector Performance: The S&P 500 Health Care Sector saw a significant gain of 9.1% in November, indicating a potential cyclical uptrend and a bullish outlook for 2026.

  • Medical Device Stocks: Notable breakouts in medical device stocks, such as IDEXX Laboratories and STERIS PLC, along with turnaround opportunities in GE Healthcare and Medtronic, suggest positive momentum in this segment.

  • iShares U.S. Medical Devices ETF (IHI): The IHI ETF shows a bullish cup-and-handle pattern and has recently broken above resistance, indicating a potential for new all-time highs and a strong performance in the coming months.

  • Long-Term Outlook: Despite a lower long-term trend compared to the S&P 500, signs of downside exhaustion in medical device stocks suggest improved performance relative to the broader market, supporting a positive outlook for 2026.

[object Object]
Preview
4.5
11-15Benzinga
Concerns Over an AI Bubble? This Industry Is Steadily Rising as Tech Declines

  • Market Performance: While technology and AI stocks are experiencing significant corrections, healthcare equities are showing resilience, with the Healthcare Select Sector SPDR Fund up nearly 6% in November, marking its best monthly performance since January.

  • Investor Trends: There has been a notable shift in investor sentiment, with healthcare recording its largest weekly inflow since January 2021, as investors seek defensive havens amid market uncertainty.

  • Valuation Comparison: Healthcare stocks are currently trading at lower valuations compared to technology stocks, with the Healthcare Select Sector SPDR Fund at a forward P/E ratio of 20x, making it an attractive option for investors concerned about high valuations in tech.

  • Top Healthcare Performers: Notable healthcare stocks like Eli Lilly, Henry Schein, and Amgen have shown significant month-to-date gains in November, highlighting the sector's strong performance amidst broader market challenges.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is STERIS plc (STE) stock price today?

The current price of STE is 261.02 USD — it has increased 0.62 % in the last trading day.

arrow icon

What is STERIS plc (STE)'s business?

STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.

arrow icon

What is the price predicton of STE Stock?

Wall Street analysts forecast STE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STE is 289.33 USD with a low forecast of 285.00 USD and a high forecast of 295.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is STERIS plc (STE)'s revenue for the last quarter?

STERIS plc revenue for the last quarter amounts to 1.46B USD, increased 9.89 % YoY.

arrow icon

What is STERIS plc (STE)'s earnings per share (EPS) for the last quarter?

STERIS plc. EPS for the last quarter amounts to 1.95 USD, increased 29.14 % YoY.

arrow icon

What changes have occurred in the market's expectations for STERIS plc (STE)'s fundamentals?

The market is revising Upward the revenue expectations for STERIS plc (STE) for FY2026, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by 6.41%.
arrow icon

How many employees does STERIS plc (STE). have?

STERIS plc (STE) has 17787 emplpoyees as of December 05 2025.

arrow icon

What is STERIS plc (STE) market cap?

Today STE has the market capitalization of 25.62B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free